|
Doctors, pharmacists must report ADRs to regulatory authorities without delay: Dr Y K Gupta
|
|
Peethaambaran Kunnathoor, Chennai
March 30 , 2017
|
|
|
The physicians as well as the pharmacists must make it a point to
identify the adverse reactions of drugs and report the same to the drug
regulatory authorities as early as possible as many of the drugs used in
India were banned in many countries, according to Dr Y K Gupta,
national scientific coordinator of the pharmacovigilance programme of
India (PvPI).
He was speaking on the subject, ‘evolution of
pharmacovigilance in India’, at a function organised by Coimbatore based
pharmacovigilance consulting company, Oviya Medsafe.
According
to him, the concept of pharmacovigilance has to be taken to the masses
because the common man must know the proper usage of medicines he often
consumes. Similarly, the concept should be included as a regular subject
in the program of continuing medical education (CME) for the medical
practitioners. Awareness needs to be given to the Indian Medical
Association and to the students of medicine, pharmacy and life sciences.
Dr.
Gupta talked about different stages of drug development including
molecular modeling, animal studies and phases of clinical trials. He
said there is tremendous scope for job opportunities for pharmacy
qualified graduates, especially for Pharm D holders, in the field of
pharmacovigilance, which is a genuine service to the mankind.
Dr N
Shanthi, professor & head of the department of pharmacology,
Coimbatore Medical College, while addressing the audience, said students
of medicine as well as of pharmacy should be encouraged to get oriented
with pharmacovigilance and choose it as a career opportunity. She said
academia-industry collaboration is much needed for advancing the science
of pharmacovigilance.
Indu Nambiar, senior manager at Boehringer
Ingelheim India Pvt Ltd, Mumbai, has opined that the country needs a
robust pharmacovigilance system, and continuous improvement is the key
for keeping quality in drugs.
According to Vasumathi Sriganesh,
CEO of QMed Knowledge Foundation in Mumbai, pharmacovigilance should be
considered as a discipline as it is a significant component of patient
safety measures. The students of medicine should take up this science as
an area of learning and practice.
Dr J Vijay Venkatraman,
managing director of Oviya Medsafe said the company is offering
professional services to many pharmaceutical companies across the
country.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|